Stay updated on ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial
Sign up to get notified when there's something new on the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page.

Latest updates to the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedA new revision entry v3.6.5 is added to the Record History and the previous revision v3.6.4 is removed, indicating an updated release/history entry for the study page.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedRevision: v3.6.4 now appears in the record history, replacing Revision: v3.6.3.SummaryDifference0.1%

- Check46 days agoChange DetectedA new revision entry v3.6.3 was added to the study record history, and the previous revision v3.6.2 was removed.SummaryDifference0.1%

- Check54 days agoChange DetectedThe study record history now includes a new revision entry for v3.6.2. The previous v3.6.0 entry has been removed.SummaryDifference0.1%

- Check68 days agoChange DetectedThe study record history shows Vojtech Melenovsky, MD, PhD listed as the responsible party, adds 'Last verified' and 'Last known status' details, and records a new Revision: v3.6.0; older entries including 'Last known status was:', 'Verified', and Revision: v3.5.5 are removed.SummaryDifference3%

- Check75 days agoChange DetectedA new revision entry v3.5.5 is now shown in the study record's history, replacing the previous v3.5.4. This indicates an update to the record's metadata.SummaryDifference0.1%

Stay in the know with updates to ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACAV: Alirocumab for Early Allograft Vasculopathy Clinical Trial page.